Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesRIV Capital Inc

RIV Capital Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None USD 0.00(0%)
Last update at 2025-01-16T19:06:58.953844Z
Market Cap
12.43M

Momentum Score

…

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and producti

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.07
Low
0.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
7.10M
Revenue Per Share
0.05
Gross Profit TTM
2.41M
Debt / Equity
1.01
ROE
-41.19%
Net Debt
32.85M
ROCE
-6.89%
Diluted EPS TTM
-0.33

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -182.18M -52.23M -120.70M -28.64M 6.25M
Minority interest - - - - 0.00M
Net income -179.26M -42.24M -106.06M -28.60M 2.93M
Selling general administrative 20.50M 7.76M 6.09M 13.03M 22.33M
Selling and marketing expenses - - - - 0.56M
Gross profit 2.44M 1.43M -43.55M 12.19M 4.87M
Reconciled depreciation 1.51M 0.22M 0.18M 0.17M -
Ebit -17.56M -9.74M -102.14M -8.57M -42.88M
Ebitda -16.04M -9.57M -101.99M -8.45M -20.50M
Depreciation and amortization 1.51M 0.18M 0.14M 0.12M 22.38M
Non operating income net other - - - - 0.00M
Operating income -22.85M -48.83M -119.18M -29.58M 6.01M
Other operating expenses 25.20M 10.45M 81.08M 13.34M 22.28M
Interest expense 17.22M 5.78M 0.02M 0.03M 0.24M
Tax provision -2.92M -12.47M -18.47M -0.05M 4.42M
Interest income 0.65M - 12.75M 4.86M 1.63M
Net interest income -16.57M -7.22M 12.72M -0.04M 1.63M
Extraordinary items - - - - 0.00M
Non recurring - - - - 0.00M
Other items - - - - 0.00M
Income tax expense -2.92M -9.99M -14.64M -0.04M 3.31M
Total revenue 6.81M 1.43M 10.10M 8.13M 3.17M
Total operating expenses 20.83M 10.45M 81.08M 13.34M 22.28M
Cost of revenue 4.37M 4.37M 53.66M -4.06M -1.70M
Total other income expense net -147.21M -37.43M -49.70M -23.41M 25.37M
Discontinued operations - - - - 0.00M
Net income from continuing ops -179.26M -52.73M -133.88M -40.57M 3.92M
Net income applicable to common shares -179.26M -52.73M -133.88M -40.57M 3.92M
Preferred stock and other adjustments - - - - 0.00M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 261.82M 366.54M 265.68M 211.81M 314.02M
Intangible assets 104.38M 0.06M - - 0.00M
Other current assets 0.02M 0.02M - - 0.00M
Total liab 152.97M 101.59M 18.94M 1.49M 8.31M
Total stockholder equity 108.85M 264.95M 246.74M 210.32M 305.71M
Deferred long term liab - - - - 0.00M
Other current liab 0.23M 0.17M 2.38M 0.15M -0.60M
Common stock 208.59M 194.46M 190.82M 200.71M 210.70M
Capital stock 208.59M 242.78M 240.87M 284.65M 281.32M
Retained earnings -320.00M -46.80M -4.91M -51.84M 33.41M
Other liab 36.88M 21.35M - - 6.97M
Good will 6.03M 6.03M - - 0.00M
Other assets 1.54M 1.73M 8.62M 47.05M 54.78M
Cash 77.47M 319.00M 101.31M 32.95M 78.03M
Total current liabilities 6.83M 3.95M 18.73M 1.19M 3.10M
Current deferred revenue 0.34M -0.17M 13.89M -0.60M -
Net debt 32.85M -238.32M -100.98M -32.55M -78.03M
Short term debt 1.06M 0.13M 0.12M 0.10M 0.10M
Short long term debt - - - - 0.00M
Short long term debt total 110.32M 80.67M 0.33M 0.40M 0.40M
Other stockholder equity 123.65M 117.29M 60.83M 61.45M 61.61M
Property plant equipment 16.91M 0.25M 0.40M 0.55M 0.00M
Total current assets 111.91M 330.49M 104.36M 40.52M 80.59M
Long term investments 21.05M 43.03M 194.61M 195.31M 256.89M
Net tangible assets -1.56M 330.78M 311.46M 298.28M 408.19M
Short term investments 20.39M 8.59M 40.44M 57.59M 64.49M
Net receivables 2.47M 9.99M 2.43M 7.39M 2.40M
Long term debt 97.36M 100.45M - - 0.00M
Inventory 9.43M 9.43M - - 0.00M
Accounts payable 5.20M 3.82M 2.33M 1.54M 3.69M
Total permanent equity - - - - 0.00M
Noncontrolling interest in consolidated entity - - - - 0.00M
Temporary equity redeemable noncontrolling interests - - - - 0.00M
Accumulated other comprehensive income 96.60M 96.60M - - 0.00M
Additional paid in capital - - - - 0.00M
Common stock total equity - - - - 0.00M
Preferred stock total equity - - - - 0.00M
Retained earnings total equity - - - - 0.00M
Treasury stock - - - - 0.00M
Accumulated amortization - - - - 0.00M
Non currrent assets other 1.32M -0.01M 0.10M 33.18M 41.03M
Deferred long term asset charges - - - - 0.00M
Non current assets total 149.91M 36.05M 161.32M 171.28M 233.43M
Capital lease obligations 12.96M 0.26M 0.42M 0.57M 0.00M
Long term debt total - - - - 0.00M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -234.90M 107.30M 123.95M -59.88M -78.26M
Change to liabilities 0.85M 1.83M 1.21M -0.94M 1.64M
Total cashflows from investing activities -234.90M 110.32M 88.23M -50.76M -129.61M
Net borrowings 22.88M 188.30M -0.17M -0.16M -0.16M
Total cash from financing activities 18.89M 149.91M 0.81M 0.79M 142.40M
Change to operating activities -1.41M 2.27M 7.09M -8.43M -3.01M
Net income -179.26M -42.24M -106.06M -28.60M 2.93M
Change in cash -241.24M 216.57M 64.29M -40.52M 43.35M
Begin period cash flow 318.71M 102.43M 37.02M 73.46M 34.68M
End period cash flow 77.47M 319.00M 101.31M 32.95M 78.03M
Total cash from operating activities -23.36M -22.74M -6.41M -5.41M -1.97M
Issuance of capital stock - - - 0.00M 198.78M
Depreciation 1.51M 0.22M 0.18M 0.17M -25.17M
Other cashflows from investing activities -1.32M -1.07M -36.30M 8.55M -51.94M
Dividends paid - 0.00M - - 0.00M
Change to inventory -0.65M -0.65M -0.58M -0.58M 0.00M
Change to account receivables 0.02M 0.02M -0.04M -0.29M 0.10M
Sale purchase of stock -3.99M -3.99M -0.24M -0.24M 0.00M
Other cashflows from financing activities 24.89M 150.05M 1.19M 0.79M -6.47M
Change to netincome 156.59M 19.74M 117.35M 42.39M -5.29M
Capital expenditures 4.55M 4.55M 4.55M 4.55M 0.11M
Change receivables - - - - 0.00M
Cash flows other operating - - - - 0.00M
Exchange rate changes - - - - 0.00M
Cash and cash equivalents changes - - - - 0.00M
Change in working capital -1.13M 2.10M 0.63M -6.81M -0.95M
Stock based compensation 0.52M 1.16M 0.74M 6.37M 18.34M
Other non cash items 157.91M 26.00M 112.74M 23.51M -0.44M
Free cash flow -27.91M -22.74M -6.41M -5.41M -1.97M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR		 -0.22
0.66%		 33.17 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.17
0.80%		 21.02 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

RIV Capital Inc

RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and producti

40 King Street West, Toronto, ON, Canada, M5H 3Y2

416-583-5945

https://www.rivcapital.com

Name Title Year Born
Mr. Mark Sims Pres, CEO & Director NA
Mr. Edward James Cirillo Lucarelli Chief Financial Officer 1988
Mr. Matthew Jonathon Mundy Chief Strategy Officer, Gen. Counsel & Corp. Sec. 1984
Mr. Peter Hatziioannou Co-Founder & Advisor NA
Mr. Sean McNulty Co-Founder & Advisor NA
Mr. Mike Totzke Chief Operating Officer NA
Ms. Amanda Rico Chief HR Officer NA
Mr. Adam Pope Analyst NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…